These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 36009030)

  • 1. In Vitro Modeling of the Blood-Brain Barrier for the Study of Physiological Conditions and Alzheimer's Disease.
    Schreiner TG; Creangă-Murariu I; Tamba BI; Lucanu N; Popescu BO
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia.
    Liu R; Collier JM; Abdul-Rahman NH; Capuk O; Zhang Z; Begum G
    Aging Dis; 2024 Aug; 15(4):1748-1770. PubMed ID: 38300642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced Human BBB-on-a-Chip: A New Platform for Alzheimer's Disease Studies.
    Yoon JK; Kim J; Shah Z; Awasthi A; Mahajan A; Kim Y
    Adv Healthc Mater; 2021 Aug; 10(15):e2002285. PubMed ID: 34075728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies.
    Alkhalifa AE; Al-Ghraiybah NF; Odum J; Shunnarah JG; Austin N; Kaddoumi A
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Rare Marine Bioactive Compounds in Neurological Disorders and Diseases: Is the Blood-Brain Barrier an Obstacle or a Target?
    Diao X; Han H; Li B; Guo Z; Fu J; Wu W
    Mar Drugs; 2023 Jul; 21(7):. PubMed ID: 37504937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells.
    Lauschke K; Frederiksen L; Hall VJ
    Stem Cells Dev; 2017 Jun; 26(12):857-874. PubMed ID: 28398169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood-brain barrier-on-a-chip: Microphysiological systems that capture the complexity of the blood-central nervous system interface.
    Phan DT; Bender RHF; Andrejecsk JW; Sobrino A; Hachey SJ; George SC; Hughes CC
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1669-1678. PubMed ID: 28195514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ-On-A-Chip Models of the Blood-Brain Barrier: Recent Advances and Future Prospects.
    Kawakita S; Mandal K; Mou L; Mecwan MM; Zhu Y; Li S; Sharma S; Hernandez AL; Nguyen HT; Maity S; de Barros NR; Nakayama A; Bandaru P; Ahadian S; Kim HJ; Herculano RD; Holler E; Jucaud V; Dokmeci MR; Khademhosseini A
    Small; 2022 Sep; 18(39):e2201401. PubMed ID: 35978444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptors and Alzheimer's disease: hitting the blood-brain barrier.
    Zolezzi JM; Inestrosa NC
    Mol Neurobiol; 2013 Dec; 48(3):438-51. PubMed ID: 23494748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Progress in Molecular Transport and Therapeutic Development in Human Blood-Brain Barrier Models in Neurological Disorders.
    Korszun-Karbowniczak J; Krysiak ZJ; Saluk J; Niemcewicz M; Zdanowski R
    Cell Mol Neurobiol; 2024 Apr; 44(1):34. PubMed ID: 38627312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo methods for imaging blood-brain barrier function and dysfunction.
    Harris WJ; Asselin MC; Hinz R; Parkes LM; Allan S; Schiessl I; Boutin H; Dickie BR
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1051-1083. PubMed ID: 36437425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease.
    Huang Z; Wong LW; Su Y; Huang X; Wang N; Chen H; Yi C
    Front Neuroendocrinol; 2020 Oct; 59():100857. PubMed ID: 32781194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a Human iPSC-Based Blood-Brain Barrier Chip.
    Jagadeesan S; Workman MJ; Herland A; Svendsen CN; Vatine GD
    J Vis Exp; 2020 Mar; (157):. PubMed ID: 32176199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revolutionizing neurotherapeutics: blood-brain barrier-on-a-chip technologies for precise drug delivery.
    Kantawala B; Shariff S; Ramadan N; Fawaz V; Hassan Y; Mugisha N; Yenkoyan K; Nazir A; Uwishema O
    Ann Med Surg (Lond); 2024 May; 86(5):2794-2804. PubMed ID: 38694300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.
    Desai BS; Monahan AJ; Carvey PM; Hendey B
    Cell Transplant; 2007; 16(3):285-99. PubMed ID: 17503739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.
    Gosselet F; Saint-Pol J; Fenart L
    Biochem Biophys Res Commun; 2014 Apr; 446(3):687-91. PubMed ID: 24275140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water-exchange MRI detects subtle blood-brain barrier breakdown in Alzheimer's disease rats.
    Dickie BR; Vandesquille M; Ulloa J; Boutin H; Parkes LM; Parker GJM
    Neuroimage; 2019 Jan; 184():349-358. PubMed ID: 30219292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recapitulation of Structure-Function-Regulation of Blood-Brain Barrier under (Patho)Physiological Conditions.
    Fong H; Zhou B; Feng H; Luo C; Bai B; Zhang J; Wang Y
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.